Peptides for the Treatment of Retinitis Pigmentosa
AssigneeConsejo Superior De Investigaciones Cientificas (Csic)
InventorsCatalina Hernandez Sanchez, Enrique de la Rosa Cano
Life of this patent
Estimating the term…
Abstract
The present invention relates to a synthetic peptide analog of the Preimplantation factor (PIF) peptide with a sequence length of maximum 20 amino acids consisting in the sequence Xaa1 Xaa2 R3 I4 K5 P6 Xaa7-20 (SEQ ID No1): wherein Xaa can be any amino acid for use in the treatment and/or prevention of Retinitis Pigmentosa and a pharmaceutical composition comprising one or more synthetic peptide analog from PIF peptides and one or more acceptable carriers.
Claims14
A method of treatment and/or prevention of Retinitis Pigmentosa comprising administering to a patient a synthetic peptide analog of the Preimplantation factor (PIF) peptide with a sequence length of maximum 20 amino acids consisting in the sequence:
- Xaa1 Xaa2 R3 I4 K5 P6 Xaa7-20 (SEQ ID No1):
- wherein:
- Xaa can be any amino acid.
Dependencies are inferred from the claim text.